Mitochondrial biogenesis: a potential therapeutic target for osteoarthritis

View/ Open
Use this link to cite
http://hdl.handle.net/2183/29053
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 España
Collections
- Investigación (FCS) [1293]
Metadata
Show full item recordTitle
Mitochondrial biogenesis: a potential therapeutic target for osteoarthritisDate
2020-05-14Citation
Blanco FJ, Fernández-Moreno M. Mitochondrial biogenesis: a potential therapeutic target for osteoarthritis.Osteoarthritis Cartilage. 2020;28(8):1003-6
Abstract
[Abstract] Mitochondrial dysfunction of human articular chondrocytes is considered a hallmark of cartilage degradation and OA pathogenesis. Due to the huge number of cellular processes in which mitochondria is implicated, even in the closed context of cellular respiration, the term mitochondrial function can refer to a variety of features which include fusion and fission, turnover (biogenesis and mitophagy), and plasticity. Mitochondrial biogenesis and mainly mitochondrial fusion and reduced mitophagy, contribute to the metabolic disorder and inflammation that occurs during OA. Reduced MFN2 and increased PARKIN expression represent potential therapeutic targets for the treatment of joint cartilage degradation during the OA process.
Keywords
Mfn2
Mitochondrial dynamics
Osteoarthritis
Mitochondrial dynamics
Osteoarthritis
Description
Editorial
Editor version
Rights
Atribución-NoComercial-SinDerivadas 3.0 España
ISSN
1063-4584